secwatch.observer — SEC 8-K summary
======================================

Issuer:     AdaptHealth Corp. (AHCO)
CIK:        0001725255
Form:       8-K
Filed at:   2023-01-11T23:59:59+00:00
Accession:  0001104659-23-002853
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AdaptHealth guides FY2023 revenue $3.21-3.29B, adj. EBITDA $690-750M; Q4 prelim near prior ranges
--------------------------------------------------------------------------------

- FY2023 net revenue guidance $3.210B-3.290B; Adjusted EBITDA $690M-$750M; capex 9-11% of revenue.
- FY2022 net revenue expected near midpoint of $2.950B-$3.010B; Adjusted EBITDA near low end of $620M-$650M.
- Non-acquired net revenue growth for 2023 estimated at 8-10%, driven by stabilizing PAP device supply.
- CEO cites strong demand but notes cost-of-goods inflation and labor pressures across healthcare.
- Full Q4 and FY2022 results scheduled for release February 28, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725255/000110465923002853/0001104659-23-002853-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725255/000110465923002853/tm233016d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-002853

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer